Cargando…
Pharmacophore-Based Similarity Scoring for DOCK
[Image: see text] Pharmacophore modeling incorporates geometric and chemical features of known inhibitors and/or targeted binding sites to rationally identify and design new drug leads. In this study, we have encoded a three-dimensional pharmacophore matching similarity (FMS) scoring function into t...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306494/ https://www.ncbi.nlm.nih.gov/pubmed/25229837 http://dx.doi.org/10.1021/jp506555w |
_version_ | 1782354331991801856 |
---|---|
author | Jiang, Lingling Rizzo, Robert C. |
author_facet | Jiang, Lingling Rizzo, Robert C. |
author_sort | Jiang, Lingling |
collection | PubMed |
description | [Image: see text] Pharmacophore modeling incorporates geometric and chemical features of known inhibitors and/or targeted binding sites to rationally identify and design new drug leads. In this study, we have encoded a three-dimensional pharmacophore matching similarity (FMS) scoring function into the structure-based design program DOCK. Validation and characterization of the method are presented through pose reproduction, crossdocking, and enrichment studies. When used alone, FMS scoring dramatically improves pose reproduction success to 93.5% (∼20% increase) and reduces sampling failures to 3.7% (∼6% drop) compared to the standard energy score (SGE) across 1043 protein–ligand complexes. The combined FMS+SGE function further improves success to 98.3%. Crossdocking experiments using FMS and FMS+SGE scoring, for six diverse protein families, similarly showed improvements in success, provided proper pharmacophore references are employed. For enrichment, incorporating pharmacophores during sampling and scoring, in most cases, also yield improved outcomes when docking and rank-ordering libraries of known actives and decoys to 15 systems. Retrospective analyses of virtual screenings to three clinical drug targets (EGFR, IGF-1R, and HIVgp41) using X-ray structures of known inhibitors as pharmacophore references are also reported, including a customized FMS scoring protocol to bias on selected regions in the reference. Overall, the results and fundamental insights gained from this study should benefit the docking community in general, particularly researchers using the new FMS method to guide computational drug discovery with DOCK. |
format | Online Article Text |
id | pubmed-4306494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-43064942015-09-17 Pharmacophore-Based Similarity Scoring for DOCK Jiang, Lingling Rizzo, Robert C. J Phys Chem B [Image: see text] Pharmacophore modeling incorporates geometric and chemical features of known inhibitors and/or targeted binding sites to rationally identify and design new drug leads. In this study, we have encoded a three-dimensional pharmacophore matching similarity (FMS) scoring function into the structure-based design program DOCK. Validation and characterization of the method are presented through pose reproduction, crossdocking, and enrichment studies. When used alone, FMS scoring dramatically improves pose reproduction success to 93.5% (∼20% increase) and reduces sampling failures to 3.7% (∼6% drop) compared to the standard energy score (SGE) across 1043 protein–ligand complexes. The combined FMS+SGE function further improves success to 98.3%. Crossdocking experiments using FMS and FMS+SGE scoring, for six diverse protein families, similarly showed improvements in success, provided proper pharmacophore references are employed. For enrichment, incorporating pharmacophores during sampling and scoring, in most cases, also yield improved outcomes when docking and rank-ordering libraries of known actives and decoys to 15 systems. Retrospective analyses of virtual screenings to three clinical drug targets (EGFR, IGF-1R, and HIVgp41) using X-ray structures of known inhibitors as pharmacophore references are also reported, including a customized FMS scoring protocol to bias on selected regions in the reference. Overall, the results and fundamental insights gained from this study should benefit the docking community in general, particularly researchers using the new FMS method to guide computational drug discovery with DOCK. American Chemical Society 2014-09-17 2015-01-22 /pmc/articles/PMC4306494/ /pubmed/25229837 http://dx.doi.org/10.1021/jp506555w Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Jiang, Lingling Rizzo, Robert C. Pharmacophore-Based Similarity Scoring for DOCK |
title | Pharmacophore-Based Similarity Scoring for DOCK |
title_full | Pharmacophore-Based Similarity Scoring for DOCK |
title_fullStr | Pharmacophore-Based Similarity Scoring for DOCK |
title_full_unstemmed | Pharmacophore-Based Similarity Scoring for DOCK |
title_short | Pharmacophore-Based Similarity Scoring for DOCK |
title_sort | pharmacophore-based similarity scoring for dock |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306494/ https://www.ncbi.nlm.nih.gov/pubmed/25229837 http://dx.doi.org/10.1021/jp506555w |
work_keys_str_mv | AT jianglingling pharmacophorebasedsimilarityscoringfordock AT rizzorobertc pharmacophorebasedsimilarityscoringfordock |